cct4

cct4

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">cct4</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CCT4</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Chaperonin Containing TCP1 Subunit 4 (Delta)</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>2p15</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>10382</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>605588</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000108771</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P50991</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>539 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~58 kDa</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Description</td>
</tr>
<tr>
<td class="label">CCT enhancers</td>
<td>Increase chaperone activity</td>
</tr>
<tr>
<td class="label">Substrate stabilizers</td>
<td>Stabilize CCT substrates</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Viral delivery of CCT subunits</td>
</tr>
<tr>
<td class="label">Combination therapy</td>
<td>With other chaperones</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Type</td>
</tr>
<tr>
<td class="label">Other CCT subunits</td>
<td>Complex members</td>
</tr>
<tr>
<td class="label">Actin</td>
<td>Substrate</td>
</tr>
<tr>

cct4

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">cct4</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CCT4</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Chaperonin Containing TCP1 Subunit 4 (Delta)</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>2p15</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>10382</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>605588</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000108771</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P50991</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>539 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~58 kDa</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Description</td>
</tr>
<tr>
<td class="label">CCT enhancers</td>
<td>Increase chaperone activity</td>
</tr>
<tr>
<td class="label">Substrate stabilizers</td>
<td>Stabilize CCT substrates</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Viral delivery of CCT subunits</td>
</tr>
<tr>
<td class="label">Combination therapy</td>
<td>With other chaperones</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Type</td>
</tr>
<tr>
<td class="label">Other CCT subunits</td>
<td>Complex members</td>
</tr>
<tr>
<td class="label">Actin</td>
<td>Substrate</td>
</tr>
<tr>
<td class="label">Tubulin</td>
<td>Substrate</td>
</tr>
<tr>
<td class="label">Hsp70</td>
<td>Co-chaperone</td>
</tr>
<tr>
<td class="label">Hsp90</td>
<td>Proteostasis network</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

The CCT4 gene encodes the delta subunit of the Chaperonin Containing TCP1 (CCT) complex, also known as TRiC (TCP-1 Ring Complex). CCT4 is one of eight distinct subunits that comprise this essential hetero-oligomeric chaperone system required for the proper folding of cytoskeletal proteins including actin and tubulin[@yaffe2002].

The CCT complex is evolutionarily conserved and represents the major cytosolic chaperone system in eukaryotes. Its function is particularly critical in cells with high protein turnover and complex morphology, such as neurons, where proper folding of cytoskeletal components is essential for synaptic function, axonal transport, and overall cellular integrity[@willison1999].

Gene Structure and Chromosomal Location

The CCT4 gene spans approximately 12 kb and consists of 12 exons. The protein is expressed ubiquitously with particularly high levels in brain tissue.

Protein Structure and Function

CCT Complex Overview

The CCT complex is a barrel-shaped chaperone consisting of eight distinct subunits[@lopez1997]:

• Ring 1: CCT1 (α), CCT2 (β), CCT3 (γ), CCT4 (δ), CCT5 (ε)
• Ring 2: CCT6 (ζ), CCT7 (η), CCT8 (θ)
• Each subunit is approximately 50-60 kDa
• Total complex mass is approximately 1 MDa

CCT4 Structural Features

CCT4 contains characteristic chaperonin domains:

• Equatorial domain: Houses the ATP-binding site, mediates inter-subunit interactions
• Apical domain: Contains substrate-binding sites, undergoes conformational changes
• Intermediate domain: Connects equatorial and apical regions

ATP-Dependent Chaperone Cycle

CCT4 participates in the CCT chaperone cycle[@kubota2005]:

Substrate Specificity

The CCT complex folds numerous substrates[@frydman2001]:

• Actin: Essential for microfilament formation
• Tubulin: Required for microtubule assembly
• Vimentin: Intermediate filament component
• Cyclins: Cell cycle regulatory proteins
• G-protein subunits: Signaling molecules
• Other substrates: Various client proteins

Role in Neurodegenerative Diseases

Alzheimer's Disease

CCT dysfunction contributes to AD through multiple pathways[@grantham2020]:

Tau pathology:

• CCT assists in tau protein folding
• Impaired function contributes to tau misfolding
• Affects phosphorylation machinery through cytoskeletal effects

• Actin dynamics at synapses require CCT
• Tubulin for axonal transport depends on CCT
• Contributes to synaptic loss in AD

• CCT capacity declines with age
• Proteostasis network becomes overwhelmed
• Contributes to aggregate formation

Parkinson's Disease

CCT in PD pathogenesis[@brasseur2020]:

Alpha-synuclein:

• CCT can interact with α-synuclein
• Modulates aggregation propensity
• Mutations affect disease progression

• Dopaminergic neurons have high protein turnover
• CCT dysfunction contributes to death
• Axonal transport impairments

Amyotrophic Lateral Sclerosis

CCT involvement in ALS[@gottstein2022]:

Protein aggregation:

• TDP-43 requires CCT for proper folding
• FUS interacts with the complex
• Dysfunction contributes to aggregation

• High metabolic demands increase CCT demand
• Becomes limiting in disease
• Therapeutic targeting explored

CCT in Brain Function

Synaptic Function

CCT is essential for synaptic processes[@spong2019]:

• Dendritic spines: Actin dynamics require proper protein folding
• Axonal transport: Microtubule function depends on tubulin folding
• Synaptic vesicle cycling: Actin-based processes need CCT
• Synaptic plasticity: Requires dynamic cytoskeletal remodeling

Neuronal Development

CCT supports neuronal development:

• Axon guidance: Cytoskeletal dynamics in growth cones
• Dendritogenesis: Proper protein folding for branching
• Synapse formation: Assembly of synaptic machinery

Glial Function

CCT in glial cells:

• Oligodendrocytes: Myelin basic protein folding
• Astrocytes: Cytoskeletal maintenance
• Microglia: Phagocytic function

Therapeutic Implications

Therapeutic Strategies

Challenges

• Complexity: Eight subunits with coordinated function
• Essentiality: Complete loss is lethal
• Specificity: Achieving selective modulation

Expression Pattern

CCT4 expression:

• Ubiquitous: Expressed in all tissues
• High in brain: Particularly in neurons
• Cytosolic: Part of the CCT complex
• Developmental: Expressed throughout development

• High in [neurons](/entities/neurons)
• Present in [astrocytes](/entities/astrocytes)
• Enriched in synaptic regions

Interaction Network

CCT4 interacts with:

Research Models

In Vitro

• Primary neuronal cultures
• iPSC-derived neurons
• Knockdown/knockout studies

In Vivo

• Cct4 knockout mice (embryonic lethal)
• Conditional knockouts
• Transgenic overexpression

Summary

CCT4 encodes the delta subunit of the CCT complex, an essential cytosolic chaperone required for folding of actin, tubulin, and numerous other substrates. CCT dysfunction contributes to neurodegenerative diseases including AD, PD, and ALS through effects on cytoskeletal integrity, synaptic function, and overall protein homeostasis. Therapeutic targeting of CCT offers potential for neuroprotection, though challenges remain in achieving specific modulation[@stadelmann2010][@valpuesta2002][@spong2019].

CCT4 in Cellular Physiology

Protein Quality Control Network

CCT4 operates within the broader proteostasis network:

• Cooperation with Hsp70: Hsp70 delivers substrates to CCT
• Proteasome collaboration: Degradation of misfolded proteins
• Autophagy connections: Aggregate clearance pathways

ATP-Dependent Chaperone Cycle

The CCT chaperone cycle is highly regulated:

Substrate Recognition

CCT has sophisticated substrate recognition:

• Hydrophobic patches: Recognizes exposed hydrophobic residues
• Co-translational folding: Assists during translation
• Co-chaperone delivery: Hsp70/Hsp40 deliver substrates

CCT4 in Aging and Neurodegeneration

Age-Related Changes

CCT function declines with age:

• Reduced expression: CCT subunit levels decrease
• Post-translational modifications: Oxidation affects function
• ATP depletion: Energy limitation impairs cycling
• Capacity exceeded: Aggregate overload

Implications

Age-related CCT decline contributes to:

• Proteostasis collapse: Impaired protein folding
• Cytoskeletal disruption: Actin/tubulin dysfunction
• Synaptic failure: Loss of synaptic proteins
• Axonal degeneration: Transport impairments

Therapeutic Target Potential

Small Molecule Modulators

• ATPase modulators: Enhance CCT cycling
• Substrate stabilizers: Protect substrates during folding
• Co-chaperone enhancers: Improve substrate delivery

Gene Therapy Approaches

• Viral delivery: AAV-mediated CCT expression
• Combination strategies: With other chaperones

Pathway Diagram

The following diagram shows the key molecular relationships involving cct4 discovered through SciDEX knowledge graph analysis:

Molecular Mechanism

CCT4 is a delta-subunit of the TRiC/CCT (Tcp1 Ring Complex / Chaperonin Containing Tcp1) complex, a ~1-MDa cylindrical chaperonin that folds actin, tubulin, and dozens of other cytoskeletal substrates in an ATP-dependent manner inside the eukaryotic cytosol. The TRiC complex consists of eight different CCT subunits (CCT1–CCT8), each contributing a distinct interface for substrate recognition; CCT4 specifically facilitates folding of β-actin and certain tubulin isotypes through a mechanism in which the substrate enters the central cavity in a partially folded state and undergoes multiple rounds of encapsulation and ATP-driven conformational cycling until native structure is achieved. Mutations in CCT subunit genes cause hereditary sensory neuropathy type I, demonstrating that impaired cytoskeletal protein quality control is sufficient to trigger neurodegeneration. In Alzheimer's disease, the TRiC complex participates in tau metabolism: proper CCT function is required for microtubule assembly downstream of tau phosphorylation events, and proteomic studies show altered CCT subunit abundance in AD brain tissue. CCT4 dysfunction leads to accumulation of misfolded cytoskeletal proteins, triggering ER stress and activating the unfolded protein response. The TRiC complex also interacts with the HSP90 system through shared substrates and cooperative client delivery, providing a failsafe for proteins that escape HSP90-mediated folding. Therapeutic strategies targeting CCT function include allosteric activators of the TRiC ATPase cycle and compounds that stabilize CCT-substrate interactions. PMID: 41104595 PMID: 31964905 PMID: 23612981 PMID: 8661059 PMID: 12874111

Pathway Diagram

The following diagram shows the key molecular relationships involving cct4 discovered through SciDEX knowledge graph analysis: